|4Feb 23, 7:56 PM ET

Ahlberg Gregory A 4

4 · ABBOTT LABORATORIES · Filed Feb 23, 2022

Insider Transaction Report

Form 4
Period: 2022-02-18
Ahlberg Gregory A
Senior Vice President
Transactions
  • Award

    Common shares without par value

    2022-02-18+11,64736,934 total
  • Award

    Option (right to buy)

    2022-02-18+54,28054,280 total
    Exercise: $117.58From: 2023-02-18Exp: 2032-02-17Common Shares (54,280 underlying)
Holdings
  • Common shares without par value

    (indirect: By Trust)
    10,825
Footnotes (3)
  • [F1]These shares represent a performance-based restricted stock award under the Abbott Laboratories 2017 Incentive Stock Program. The award has a 3-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The award includes the right to have shares withheld for tax purposes.
  • [F2]Balance in the Abbott Laboratories Stock Retirement Trust as of February 18, 2022.
  • [F3]Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 18,093 on February 18, 2023, 18,093 on February 18, 2024, and 18,094 on February 18, 2025.

Documents

1 file
  • 4
    form4-02232022_040210.xmlPrimary